Regulation & policy
FDA considers rulemaking and enforcement discretion on DSHEA disclaimer
In a letter to the dietary supplements industry, the FDA’s deputy commissioner for human foods says the agency is considering a regulatory amendment regarding requirements around the DSHEA disclaimer on product labels.
Guest article
When transparency becomes selective: GRAS vs. dietary supplement listings
Transparency has suddenly become one of the most talked-about themes in today’s food and consumer safety debates. Policymakers are pressing for more visibility into the ingredients entering the food supply, and the momentum behind reforming the...
‘There was never a dull moment’: 8 reasons to attend the IPA World Congress + Probiota 2026
The IPA World Congress + Probiota 2026 is just two months away! The leading event for the probiotics, prebiotics and microbiome community is a must-attend event, and let us tell you why…
FDA reinstates NDI status of NMN with new letters to ingredient players
The U.S. Food and Drug Administration has sent letters to specific NMN ingredient suppliers confirming it has set aside previous determinations that the vitamin B3 form is excluded from the definition of a dietary supplement.
Guest article
Welcoming the age of MAHA with persistence, patience and pragmatism
What a year of transition, uncertainty and unpredictability 2025 has been—not just for the dietary supplement industry, but for all of us navigating rapid change. From shifting tariff rates to upheaval at FDA, from renewed pushes to restrict access to...
New NIH initiative boosts systems-based nutrition research
The National Institutes of Health has launched a five-year project to develop a unified model of healthy human physiology, signaling a shift toward whole-person health that aligns with longstanding approaches in the nutrition and supplements sector.
NutraCast: How US trade policy is disrupting the supplement supply chain, threatening quality
Tariffs meant to boost U.S. manufacturing might actually be pushing companies away from American investment. Chase Johnston, vice president of operations at Arjuna Natural, breaks down how rapidly shifting tariff rates are creating chaos for the...
FDA seizes $1 million in 7-OH products
The U.S. Marshals Service has seized approximately 73,000 units of 7-hydroxymitragynine (7-OH) products from three firms in Missouri, the U.S. FDA announced.
Across the Nutraverse: Hi-Tech Pharmaceuticals CEO convicted, Vitamin B6 in Australia, creatine
Catch up with our weekly round-up of key news from across the Nutraverse.
CRN updates vitamin K2 MK-7 intake limits
The Council for Responsible Nutrition (CRN) has determined a Highest Observed Intake (HOI) level for vitamin K2-MK7 of 375 mcg/day following a review of over 40 clinical trials.
SSG 2025: Asa Waldstein on FDA, FTC and NAD enforcement trends
Apex Compliance’s Asa Waldstein shares valuable insights for those seeking to avoid an FDA warning letter, a competitor case with the NAD or a referral to the FTC due to ad claims non-compliance.
News in brief
HHS brings back NHANES staff for public health
The Department of Health and Human Services (HHS) has rescinded the reduction in force notices for staff involved with the National Health and Nutrition Examination Survey (NHANES) following public pressure to recognize the importance of the survey for...
Michigan legislator introduces restrictive supplements bill
A lawmaker in Michigan has filed a bill to prohibit the sale of weight loss and muscle building products to minors. The Council for Responsible Nutrition said the bill is “premised on a misunderstanding of both the science and the regulation of dietary...
White House updates tariffs with relief for some botanicals
The Trump Administration has revised and expanded the tariff exemption list to include botanicals such as green and black tea, cinnamon, ginger and turmeric.
Founder urges women’s health brands to lobby against red tape
The founder of premium women’s health supplement brand Lyma signaled an opportunity for UK brands to contest health claim restrictions during last week’s Nutra Healthspan Summit.
CHPA’s MacKay on growth, challenges, MAHA and going mainstream
The Dietary Supplement Health and Education Act (DSHEA) was signed into law in 1994 by President Bill Clinton, creating the modern dietary supplements industry as we know it. When DSHEA passed, the industry had 4K products and was worth $4 billion....
IPA chief on the end of self-GRAS, China’s probiotic growth and global regulatory uncertainty
The International Probiotics Association (IPA) has mobilized its regulatory affairs committee to address expected changes to the GRAS affirmation pathway. “We’ve been very active, proactive,” says George Paraskevakos.
CRN’s Mister on the regulatory curveball nobody saw coming
The Trump Administration returned to the White House one year ago. From Robert F. Kennedy Jr. being named health secretary, to tariffs, to Make America Healthy Again, it’s been an eventful year for a variety of sectors—including dietary supplements.
ANH pushes FDA to broaden access to medical foods
The Alliance for Natural Health (ANH) USA is calling for FDA regulatory reform to broaden access to medical foods, with the aim of using nutrition therapies to help manage chronic disease and other conditions.
Fabricant on government shutdown, NMN and 90 years of NPA
The ongoing government shutdown is impacting GMP inspections and delaying proposals to amend the Generally Recognized as Safe (GRAS) regulation. “We’re gonna just sit on our hands for a little while longer,” says Dr. Daniel Fabricant, president and CEO...
FDA flags more supplements adulterated with toxic yellow oleander
The US Food and Drug Administration (FDA) has updated its ongoing safety alert regarding dietary supplements adulterated with yellow oleander, expanding its watchlist following analytical testing.
‘Confusing’ and ‘shocking’: Elimination of lawful marketing leaves regulatory experts with more questions than answers
During the Council for Responsible Nutrition (CRN) Convergence ‘25 Conference, a panel dissected the FDA’s Sept. 29 response to citizen petitions regarding dietary supplement regulations. While nicotinamide mononucleotide (NMN) received some regulatory...
Q&A: Supplement brands face new AI decision-making rules
The California Consumer Privacy Act (CCPA) has implications for dietary supplement stakeholders. In this Q&A, Nikki Bhargava, a partner in the Emerging Technologies group at global law firm Reed Smith breaks down what you need to know.
‘A pivotal expansion’: European inulin producers join IPA
The European Association of Chicory Inulin Producers (CEFI) has joined the International Probiotics Association, a move that IPA calls “a pivotal expansion in the representation of prebiotic science and industry worldwide”.
Dietary supplements no longer included in AB 899
After going back and forth with CA lawmakers over whether supplements are included in the legislation, CRN reports that it has secured clarifying language with the enactment of SB 862.
NutraCast: The Vitamin Angels push to close maternal nutrition gaps
Nutritional maternal health in the U.S. has high rates of nutrient deficiencies, leading to risks like anemia, preeclampsia, low birth weight and significantly higher maternal mortality rates.
The ‘proteinification’ of everything
Once just a bottle shaker staple, protein is taking on new forms and finding its way into everything from soda to chips to macaroni and cheese.
DuelFuel founder relaunches protein bars after VAT battle comes to ‘tragic’ end
An entrepreneur has relaunched his ’perform and recover’ protein bars after reaching the ‘tragic’ end of a three-and-a-half-year legal battle with the HMRC, stating “only consumers can decide our fate.”
Crow-dipper rhizome deemed not novel, national barriers remain
The European Commission has updated the EU Novel Food Catalogue to confirm that crow-dipper rhizome and its alcoholic extract of Pinellia ternata are not considered novel when used in food supplements.
FDA declares NMN lawful in dietary supplements
The U.S. Food and Drug Administration (FDA) has responded to a Citizen Petition from the Natural Products Association (NPA) and the Alliance for Natural Health USA (ANH) on the status of NMN, declaring the vitamin B3 form to be lawful for use in dietary...
NutraCast: Well-intentioned regulations that could backfire
The Council for Responsible Nutrition is ringing the alarm on two bills, one impacting pregnant women in California, the other, minors in New York.
Ryze Superfoods drops mushroom coffee and matcha health claims after NAD inquiry
The case highlights compliance risk for functional beverages and ingredient claims among dietary supplement and food‐adjacent product manufacturers.
Sustainability September
The women driving sustainability
NutraIngredients sat down with the women championing sustainability efforts to discuss initiatives they’re working on, the challenges that exist and the push for progress.
MAHA: Putting the ‘F’ back in FDA
The Make America Healthy Again movement has placed more focus on food and nutrition than ever before, and FDA is here for it.
Professor disputes low vitamin D limit recommendation
Dr. Manfred Eggersdorfer, professor for healthy aging at the University of Groningen in the Netherlands, has outlined a number of studies which call into question the recent assessment issued by a recent German report.
Regulatory trends: Novel formats, unannounced inspections and the ‘high‑quality’ question
The health and wellness industry is facing a regulatory maze as companies push boundaries with innovative products that do not fit traditional FDA categories, says Shelly Blackwell from EAS Consulting Group.
Dr. Vegan challenges ‘overmedicalization of menopause’ in wake of ASA ruling
The founder of a brand called-out by the ASA argues that the ruling is an example of the over-medicalization of women’s health, creating red tape for those attempting to support women through diet and supplements.
Does the research back ashwagandha safety concerns?
A major scientific review highlights critical knowledge gaps in ashwagandha’s effects on pregnancy and fertility as the EU and UK consider safety-related restrictions.
Supplement weight management claims in the GLP-1 era
Earlier this year, California resident Christina Robins sued wellness brand Lemme Inc. accusing it of misleading marketing practices surrounding the company’s GLP-1 Daily supplement.
New administration, new outlook: FDA homes in on leveraging internal and external resources
During CHPA’s FDA Leadership Panel, ODSP’s Cara Welch detailed her department’s priorities, which include strengthened regulations, leveraging resources and stakeholder engagement.
Three states propose laws targeting GRAS, while more than 100 more bills aim to block controversial additives
Surge in legislative proposals ‘comes in the background of misinformation’, according to one expert
Sports & Active Nutrition Summit 2026: SF 49ers, Herbalife and Front Row headline speaker list
With expert speakers confirmed from iHerb, SPINS, Herbalife, the San Francisco 49ers, AHPA, CPG Radar, Front Row, Gifted Wellness, High Performance Nutrition, the University of Arkansas and more, the upcoming Sports & Active Nutrition Summit is not to be...
Eliminating self-affirmed GRAS? FDA advancing proposals to amend food ingredient regulations
The U.S. Food and Drug Administration’s proposals to amend the Generally Recognized as Safe (GRAS) regulation are expected in October.